Nuveen ESG Mid-Cap Growth (NUMG) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Nuveen ESG Mid-Cap Growth (NUMG) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $435.6M, listed on CBOE, carrying a beta of 1.26 to the broader market. The Fund employs a passive management (or “indexing”) approach, investing primarily in mid-capitalization U. public since 2016-12-20.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for NUMG as of 2026-06-01; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.